Efficacy and safety of Tengfu Jiangya tablet combined with valsartan/amlodipine in the treatment of stage 2 hypertension: study protocol for a randomized controlled trial
DiscussionThis is the first placebo-controlled randomized trial conducted to evaluate the efficacy and safety of a Chinese herbal extract combined with Val/Aml in patients with stage 2 hypertension. Our study may help to provide evidence-based recommendations of a complementary preventive measure for stage 2 hypertension.Trial registrationChinese Clinical Trial RegistryChiCTR2000030611. Registered on 8 March 2020 (Source: Trials)
Source: Trials - February 22, 2022 Category: Research Source Type: clinical trials
Sacubitril/Valsartan for CKD5 Stage Dialysis Patients With Heart Failure
Condition: Cardiac Function and Survival Interventions: Drug: Sacubitril/Valsartan; Drug: Irbesartan Sponsor: Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2022 Category: Research Source Type: clinical trials
